Regular oral use of smokeless tobacco

Malignant neoplasm of the oral cavity and oropharynx and hypopharynx - Regular oral use of smokeless tobacco Factor

Last reviewed for CCPS 05 October 2005.

Investigative Documents

Claimant Report - Oral Use of Smokeless Tobacco - Malignant Neoplasm of the Oral Cavity, Oropharynx and Hypopharynx [CR9161]

Preliminary questions [14355]

27941

there is some evidence that the oral use of smokeless tobacco may be a factor in the development of the condition under consideration.

15771 the veteran has engaged in the oral use of smokeless tobacco on more days than not for an extended period at some time.

15773 — the veteran has established the causal connection between the oral use of smokeless tobacco and VEA service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

15776 — the veteran has established the causal connection between the oral use of smokeless tobacco and operational service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

or

15778 — the veteran has established the causal connection between the oral use of smokeless tobacco and eligible service for the clinical onset of the malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

Clinical onset and operational service [15776]

15774

the veteran practised the oral use of smokeless tobacco on more days than not for at least five years before the clinical onset of the condition under consideration, and where such usage has ceased the clinical onset has occurred within fifteen years of cessation.

27943

operational service made a material contribution to the veteran's oral use of smokeless tobacco on more days than not for at least five years which continued to within fifteen years of the clinical onset of the condition under consideration.

Clinical onset and eligible service [15778]

15777

the veteran practised the oral use of smokeless tobacco on more days than not for at least ten years before the clinical onset of the condition under consideration, and where such usage has ceased the clinical onset has occurred within ten years of cessation.

27946

eligible service made a material contribution to the veteran's oral use of smokeless tobacco on more days than not for at least ten years which continued to within ten years of the clinical onset of the condition under consideration.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oral-cavity-oropharynx-and-hypopharynx-b034-140314041405141/rulebase-malignant-neoplasm-oral-cavity-and-oropharynx-and-hypopharynx/regular-oral-use-smokeless-tobacco